Skip to main content
ConductScienceScienceDex

Leif W Ellisen

NIH Rank #1155
Unclaimed recordClaim profile
  • R01 Holder
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1980799Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$3.4M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#1,155
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Leif W Ellisen. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Leif W Ellisen as a PI. Multi-PI records show the full award amount for context.

  • 4R01CA294793-03R01
    Elucidating resistance mechanisms and enhancing response to immune checkpoint blockade in central nervous system metastases from breast cancer
    Massachusetts General Hospital
    $2.1M
    award amount
  • 5R01CA248923-05R01
    Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans
    Massachusetts General Hospital
    $784.1K
    award amount
  • 5R01CA260890-05R01
    Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer
    Massachusetts General Hospital
    $559.8K
    award amount

Award organization

Organizations that administered FY2026 awards listing Leif W Ellisen as a PI.

FY2026 award administered by Massachusetts General Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5515
  5. 2025
    $2M Cumulative Funding
  6. 2025
    R01 Grant Holder
  7. 2026
    $5M Cumulative Funding
  8. 2026
    Entered Top 25% Nationally
    Ranked #1155
  9. 2026
    Entered Top 10% Nationally
    Ranked #1155

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Leif W Ellisen.

Aditya Bardia
Massachusetts General Hospital
3
shared awards
Naomi Yu Ko
Massachusetts General Hospital
3
shared awards
Priscilla Kaliopi Brastianos
Massachusetts General Hospital
3
shared awards
Deborah A. Dillon
Dana-Farber Cancer Institute
1
shared award
Esther Rheinbay
Massachusetts General Hospital
1
shared award
Geoffrey I. Shapiro
Dana-Farber Cancer Institute
1
shared award
Judy E. Garber
Dana-Farber Cancer Institute
1
shared award
Kornelia Polyak
Dana-Farber Cancer Institute
1
shared award
Myles A Brown
Dana-Farber Cancer Institute
1
shared award
Nabihah Tayob
Dana-Farber Cancer Institute
1
shared award

Explore further

Find collaborators for Leif W Ellisen

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →